AI-Based Automated Image Analysis: The locked automated method will use chest radiographic image analysis and a patient-specific Delta adjustment to estimate port catheter tip position. The method will be evaluated offline using reference measurements derived from clinically indicated post-implantation noncontrast chest computed tomography. Its output will not be provided to the clinical team and will not guide port implantation or alter clinical decisions.
Manual A+B Measurement Method: The prespecified manual A+B method will estimate port catheter tip position using manual measurements on the pre-implantation chest radiograph. It will be applied as a comparator in the same participants. The manual research measurement will not guide port implantation or alter clinical care.
Study summary
This prospective, single-center observational study will evaluate the performance of an artificial intelligence (AI)-based automated image-analysis method that will be developed, internally tested, and locked before prospective enrollment. The method will estimate the position of totally implantable venous access port catheter tips in adults undergoing right internal jugular vein port implantation as part of routine care. The automated estimate will be compared with a prespecified manual measurement method. Reference measurements of the catheter tip and the cavoatrial junction will be obtained from clinically indicated chest computed tomography images when both structures are visible. No additional chest radiography or computed tomography will be performed for research purposes, and the automated output will not guide catheter placement or alter clinical decisions. The primary performance measure will be the mean absolute error of the automated estimate in the prospective cohort.
Eligibility
Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria:
* Age 18 years or older.
* Planned placement of a totally implantable venous access port through the right internal jugular vein as part of routine clinical care.
* Availability of a suitable pre-implantation chest radiograph obtained as part of routine clinical care.
* Availability of a clinically indicated post-implantation noncontrast chest computed tomography examination.
* Absence of documented catheter manipulation or revision before the selected post-implantation computed tomography examination.
* Provision of written informed consent.
Exclusion Criteria:
* Age younger than 18 years.
* Cancellation of the routine clinical port implantation plan.
* Planned or performed port placement through a venous access route other than the right internal jugular vein.
* No suitable pre-implantation chest radiograph available for study assessment.
* Advanced thoracic deformity or mediastinal distortion precluding the required study measurements.
* Inability or unwillingness to provide written informed consent.
Primary outcome measure(s)
Mean Absolute Error of Catheter Advancement Length Estimated by the AI-Based Automated A+B+Delta Method — At the first eligible post-implantation noncontrast chest computed tomography examination obtained during routine care, before any documented catheter manipulation or revision Mean absolute error (MAE), in millimeters, will be calculated as the arithmetic mean of the absolute differences between the catheter advancement length estimated by the locked AI-based automated A+B+Delta method and the reference catheter advancement length derived from the first eligible post-implantation noncontrast chest computed tomography examination. The analysis population will include participants with both a valid automated output and an evaluable reference measurement. Lower values indicate smaller estimation error. A 95% confidence interval will be estimated using 10,000 participant-level bias-corrected and accelerated bootstrap resamples.
Trial sites (1)
Facility
City
Region
Status
Bagcilar Training and Research Hospital
Bağcılar
Istanbul
More Bagcilar Training and Research Hospital trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.